Back

Bidirectional Peptide Conformation Prediction for MHC Class II using PANDORA

Rademaker, D. T.; Parizi, F. M.; van Vreeswijk, M.; Eerden, S.; Marzella, D.; Xue, L.

2025-01-31 immunology
10.1101/2024.11.04.621877 bioRxiv
Show abstract

Recent discoveries have transformed our understanding of peptide binding in Major Histocompatibility Complex (MHC) molecules, showing that peptides, for some MHC class II alleles, can bind in a reverse orientation (C-terminus to N-terminus) and can still effectively activate CD4+ T cells. These finding challenges established concepts of immune recognition and suggests new pathways for therapeutic intervention, such as vaccine design. We present an updated version of PANDORA, which, to the best of our knowledge, is the first tool capable of modeling reversed-bound peptides. Modeling these peptides presents a unique challenge due to the limited structural data available for these orientations in existing databases. PANDORA has overcome this challenge through integrative modeling using algorithmically reversed peptides as templates. We have validated the new PANDORA feature through a series of experiments, achieving an average backbone binding-core L-RMSD value of 0.63 [A]. Notably, it maintained low RMSD values even when using templates from different alleles and peptide sequences. Our results suggest that PANDORA will be an invaluable resource for the immunology community, aiding in the development of targeted immunotherapies and vaccine design. AvailabilitySource code and data is freely available at https://github.com/X-lab-3D/PANDORA; Contact: Li.Xue@radboudumc.nl

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.